碘伏湿敷联合外用重组人表皮生长因子喷剂治疗溃疡期压疮的临床疗效.docVIP

碘伏湿敷联合外用重组人表皮生长因子喷剂治疗溃疡期压疮的临床疗效.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
碘伏湿敷联合外用重组人表皮生长因子喷剂治疗溃疡期压疮的临床疗效.doc

碘伏湿敷联合外用重组人表皮生长因子喷剂治疗溃疡期压疮的临床疗效   【摘要】 目的:探讨碘伏湿敷联合外用重组人表皮生长因子喷剂治疗溃疡期压疮的疗效。方法:选取2012年1月-2014年12月本院收治的溃疡期压疮患者109例作为研究对象,采用随机数字表法分为对照组52例与观察组57例,对照组采用传统方法治疗,即用生理盐水清洁创面后,用凡士林纱布及敷料包扎。观察组采用碘伏湿敷联合外用重组人表皮生长因子喷剂治疗。观察两组压疮愈合情况。结果:对照组52例患者共出现61处压疮,治疗总有效率85.2%,观察组57例患者共出现67处压疮,治疗总有效率100%,观察组治疗效果优于对照组,比较差异有统计学意义(P0.01)。结论:碘伏湿敷联合外用重组人表皮生长因子喷剂治疗压疮有效率高。   【关键词】 压疮; 碘伏湿敷; 重组人表皮生长因子; 护理   The Clinical Effects of Recombinant Human Epidermal Growth Factor Combined with Iodophor Hydropathic Compress in the Treatment of Ulcer Stage Pressure Sores/LIU Gui-rong,YANG Kun,PANG Xiu-qing,et al.//Medical Innovation of China,2016,13(10):105-108   【Abstract】 Objective:To investigate the effects of Recombinant Human Epidermal Growth Factor combined with Iodophor hydropathic compress in the treatment of ulcer stage pressure sores.Method:109 cases of ulcer stage pressure sores patients in our hospital from January 2012 to December 2014 were randomly divided into the control group of 52 cases and the observation group of 57 cases,the control group was treated with the traditional method,including wrapping with vaseline gauze and dressing after saline to clean the wound and the observation group used Iodophor wet dressing combined with Recombinant Human Epidermal Growth Factor spray treatment,the healing situation of pressure ulcers of the two groups were observed.Result:52 patients of the control group were with a total of 61 pressure ulcers,the total effective rate was 85.2%,57 patients in the observation group were with a total of 67 pressure ulcers,the total effective rate was 100%,thetreatment effective of the observation group was significantly better than that of the control group,the difference was statistically significant(P0.01).Conclusion:Recombinant Human Epidermal Growth Factor combined with Iodophor hydropathic compress in the treatment of ulcer stage pressure sores has a good effect.   【Key words】 Pressure sore; Iodophor hydropathic compress; Recombinant Human Epidermal Growth F

文档评论(0)

yingzhiguo + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:5243141323000000

1亿VIP精品文档

相关文档